In 1943 was created Laboratorios Ordesa, which is appeared as Corporate Investor.
Among the various public portfolio startups of the fund, we may underline Oryzon Genomics Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most successful fund investment fields, there are Therapeutics, Biotechnology.
The fund is constantly included in less than 2 investment rounds annually. The higher amount of exits for fund were in 2015. The top activity for fund was in 2008. Deals in the range of 10 - 50 millions dollars are the general things for fund.
The typical case for the fund is to invest in rounds with 2 participants. Despite the Laboratorios Ordesa, startups are often financed by Najeti Capital, Grupo Ferrer Internacional. The meaningful sponsors for the fund in investment in the same round are Corsabe Capital. In the next rounds fund is usually obtained by Alzheimer's Drug Discovery Foundation.
Related Funds
| Fund Name | Location |
| ALPLA | - |
| Anicom | Japan, Tokyo |
| CareCentrix | Connecticut, East Hartford, United States |
| Echo Health Ventures | Seattle, United States, Washington |
| EVO Venture Partners | Amsterdam, Noord-Holland, The Netherlands |
| Fashion Zone | Canada, Ontario, Toronto |
| Gefen Biomed Investments | Ashkelon, HaDarom, Israel |
| Qatar Holding | China, Hong Kong, Jordan |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Oryzon Genomics | $12M | 12 Mar 2008 | Community of Madrid |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Oryzon Genomics | $12M | 12 Mar 2008 | Community of Madrid |
